prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Normal, FOI. Specimen #: 'Age: pare: AMENDED. SPECIMEN: A: LEFT BREAST MASTECTOMY B: RIGHT BREAST. FINAL DIAGNOSIS: A. BREAST, LEFT MASTECTOMY: - MODERATELY DIFFERENTIATED INFILTRATING LOBULAR CARCINOMA WITH. LOBULAR CARCINOMA IN SITU, EXTENDING INTO THE MILK DUCTS AND SKIN OF. THE NIPPLE AND INVOLVING THE UPPER OUTER QUADRENT, AND EXTENDING. WITHIN 1MM OF (BUT NOT INVOLVING) THE DEEP SURGICAL MARGIN. ATYPICAL LOBULAR HYPERPLASIA INVOLVING THE LOWER INNER QUADRANT AND. LOWER OUTER QUADRANT. B. BREAST, RIGHT) MASTECTOMY: - LOBULAR CARCINOMA IN SITU (1MM) WITH EXTENSIVE LOBULAR HYPERPLASIA. - ATYPICAL LOBULAR HYPERPLASIA. - FIBROCYSTIC CHANGES INCLUDING CYSTS, FIBROSIS, AND APOCRINE. METAPLASIA. COMMENT #1: ESTROGEN RECEPTORS : NEGATIVE. PROGESTERONE RECEPTORS: POSITIVE (80-90% OF NUCLEAR SUTAINING). COMMENT #2: HER2/NEU (FISH METHODOLOGY) : NOT AMPLIFIED (1.1). CLINICAL DIAGNOSIS AND HISTORY: -year-old with left infiltrating lobular carcinoma by biopsy. Scheduled. for bilateral mastectomy and left sentinel node biopsy. PRE-OPERATIVE DIAGNOSIS: Left breast carcinoma. TC. Specimen #: GROSS DESCRIPTION: A. LEFT BREAST MASTECTOMY received fresh is a 243.0 gram simple mastectomy. specimen, 15.5 x 15.0 x 3.3 cm, with overlying ellipse of nipple bearing. skin, 4.8 x 3.3 cm. The skin and nipple are unremarkable. The specimen is. oriented with sutures (long=lateral, short=superior) and inked as follows : Blue-superior superficial, green-inferior superficial, and. black-posterior. Sectioning reveals a 3.2 x 3.0 x 2.0 cm tumor centrally. extending into the upper inner quadrant. The tumor has poorly defined. stellate borders and a firm, tan, gritty cut surface. It is located 0.3 cm. from the inked posterior margin. The remaining tissue is predominantly. fibrous with a few admixed fluid filled cysts. Sections of skin, tumor,. and grossly unremarkable fibrous tissue harvested for the CBCP protocol;. matching paraffin sections are as follows: A1: Skin, medial tip. A2: Tumor, lateral portion. A3: Fibrous, 1.0 cm inferior to tumor. A4: Fibrous, 2.0 cm inferior to tumor. A5: Fibrous, 5.0 cm inferior to tumor. Sections through the nipple are placed in cassette labeled A6. There is no. surgical scar visible. There is a detached fragment of skin measuring 3.4. x 2.1 x 1.6 cm. A representative section from this tissue fragment is. placed in cassette A7. Representative sections of tumor are placed in. cassettes A8 through A10. Other representative sections are as follows: All: Upper inner quadrant. A12 Lower inner quadrant. A13: Lower outer quadrant. A14: Upper outer quadrant. 14CFSS. B. RIGHT BREAST received fresh is a 336.0 gram simple mastectomy specimen,. 18. x 12.5 x 2.5 cm. The specimen is oriented with sutures (long-lateral,. short-superior) and inked as follows Blue-superior superficial,. green-inferior superficial, black-posterior. The specimen is serially. sectioned revealing predominantly fibrous tissue with scattered admixed. cysts measuring up to 1.2 cm in diameter. No disctete masses are. identified. One section of each, skin and fibrous tissue (lower outer. quadrant) are harvested for the CBCP protocol; mirror images for Histology. are in cassettes B1 and B2 respectively. There is no visible scar in the. overlying nipple/areola. Sections from the areola are placed in cassette. B3. Representative sections from the 1.2 cm cyst from the central superior. quadrant (centrally between the upper inner and upper outer quadrant) are. placed in cassette B4. Representative sections are placed as follows. Specimen # : GROSS DESCRIPTION (continued) : B5-B6: Upper outer quadrant. B7-B8: Lower outer quadrant. B9-B10: Lower inner quadrant. B11-B12: Upper inner quadrant. 12CFSS.

expanded version (tokens=1466) : 
 The breast pathology report provides the following information:

1. Histological classification: 
a. Left Breast Mastectomy: Moderately differentiated infiltrating lobular carcinoma with lobular carcinoma in situ that extends into the milk ducts and skin of the nipple, and involves the upper outer quadrant. Additionally, the report mentions the presence of atypical lobular hyperplasia in the lower inner quadrant and lower outer quadrant.
b. Right Breast Mastectomy: Lobular carcinoma in situ (1mm) with extensive lobular hyperplasia. The report also mentions the presence of atypical lobular hyperplasia and fibrocystic changes, including cysts, fibrosis, and apocrine metaplasia.

2. Subtype: Normal, FOI

3. Description of any necrosis: Not mentioned in the report.

4. Tumor infiltrating lymphocytes: Not mentioned in the report.

5. Histological grade: Not mentioned in the report.

6. Nuclear grade: Not mentioned in the report.

7. Lymphovascular invasion: Not mentioned in the report.

8. Calcification: Not mentioned in the report.

9. Receptor status:
a. Estrogen receptors: Negative
b. Progesterone receptors: Positive (80-90% of nuclear staining)
c. HER2/neu: Not amplified (1.1)

10. IHC and other ancillary testing results: Not mentioned in the report.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1625) : 
 The breast pathology report reveals moderately differentiated infiltrating lobular carcinoma with lobular carcinoma in situ in the left breast mastectomy. The tumor extends into milk ducts and nipple skin. Atypical lobular hyperplasia is present in several areas. The right breast mastectomy shows 1mm lobular carcinoma in situ along with atypical lobular hyperplasia and fibrocystic changes. Estrogen receptors are negative, while progesterone receptors are positive. HER2/neu is not amplified. No other relevant information is available in the report.

